Brainstorm Cell Therapeutics (BCLI) Operating Leases (2019 - 2025)
Brainstorm Cell Therapeutics (BCLI) recorded Operating Leases of $50,000 in Q3 2025, down 81.5% from $271,000 a year earlier and down 47.4% from the prior quarter.
Powered by 
Analysis
Brainstorm Cell Therapeutics (BCLI) Operating Leases (2019 - 2025) Analysis & Trends
At the end of FY2024, Brainstorm Cell Therapeutics reported Operating Leases of $171,000, down 74.6% from FY2023.
- Annual Operating Leases has declined for four straight years, with a five-year compound annual growth rate of -31.1% (FY2019 to FY2024).
- Across earlier years, Operating Leases came in at $672,000 in FY2023 (-74.8%), $2.67 million in FY2022 (-26.3%), $3.62 million in FY2021 (-20.7%) and $4.56 million in FY2020 (+313.6%).
- The Q3 2025 figure is the lowest quarterly Operating Leases in data going back to Q1 2019.
- On a year-over-year basis, Operating Leases has declined for 16 consecutive quarters, with an average decline of 77.8% over the last eight quarters.
- Peak year-over-year performance for Operating Leases in the last five years was growth of 616.3% in Q2 2021, against a decline of 82.9% in Q3 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $95,000 (Q2 2025), $127,000 (Q1 2025) and $171,000 (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Brainstorm Cell Therapeutics | 8.50 Mn | 8.43 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 50,000.00 |
| Jun 30, 2025 | 95,000.00 |
| Mar 31, 2025 | 127,000.00 |
| Dec 31, 2024 | 171,000.00 |
| Sep 30, 2024 | 271,000.00 |
| Jun 30, 2024 | 396,000.00 |
| Mar 31, 2024 | 533,000.00 |
| Dec 31, 2023 | 672,000.00 |
| Sep 30, 2023 | 1.59 Mn |
| Jun 30, 2023 | 1.94 Mn |
| Mar 31, 2023 | 2.29 Mn |
| Dec 31, 2022 | 2.67 Mn |
| Sep 30, 2022 | 2.92 Mn |
| Jun 30, 2022 | 3.26 Mn |
| Mar 31, 2022 | 3.93 Mn |
| Dec 31, 2021 | 3.62 Mn |
| Sep 30, 2021 | 3.77 Mn |
| Jun 30, 2021 | 4.00 Mn |
| Mar 31, 2021 | 4.18 Mn |
| Dec 31, 2020 | 4.56 Mn |
API Access
Brainstorm Cell Therapeutics Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=BCLI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "BCLI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=BCLI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();